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Background:  Percutaneous pulmonary valve implant (Melody) for conduit related pulmonary stenosis (PS) or pulmonary insufficiency 
(PI) has gained rapid acceptance. However, objective data regarding the benefit of this therapy with regard to the incidence of arrhythmias 
remains limited.
methods:  As part of the phase I Melody valve clinical trial, 141 patients with congenital heart disease underwent serial cardiopulmonary 
exercise testing (CPET) prior to and 6 months post implant. Arrhythmias during CPET were defined as premature ventricular contractions 
(PVCs) and supraventricular or ventricular tachycardia (VT). The most common anatomic subtypes were tetralogy of Fallot, aortic stenosis 
(post Ross procedure) and transposition variants. The mean age at implantation was 22.4±0.9 years, range 7-53 years.
results:  Prior to Melody implant, PVC’s were common, occurring in 57 (40%) of the patients. While no subjects had sustained 
arrhythmias, 2 had non-sustained VT and 3 had non-sustained supraventricular tachycardia. Following Melody implant, there was no 
significant change in the incidence or type of arrhythmias during exercise: 38 patients (27%) had PVCs during CPET both pre and post 
implant, 19 patients (14%) who had PVCs pre implant did not have PVCs post implant, whereas 22 pts (16%) who did not have PVCs pre-
implant did have PVCs post implant. No patient had supraventricular tachycardia and 1 different patient had non-sustained VT post implant. 
Subgroup analysis of PS or PI (or mixed), anatomic sub-type, and pre-implantation right ventricular dimensions did not demonstrate a 
significant benefit for Melody valve implant. Although right ventricular function and volume were improved following implantation, these 
changes were not predictive of resolution or prevention of new-onset PVCs.
Conclusion:  Melody valve implant for PS or PI did not result in resolution or prevention of PVCs or other arrhythmias during CPET despite 
improvement in hemodynamics. PVCs may be related to the basic heart defect, focal scarring, fibrosis or surgical suture lines rather than 
pulmonary valve dysfunction. A cautious appraisal of the effect of Melody valve implant on arrhythmia burden appears warranted.
